PILAKCHALI PSORIAZDA SKAFO PREPARATINING KLINIK SAMARADORLIGI VA XAVFSIZLIGI | Dermatovenereology and aesthetic medicine

PILAKCHALI PSORIAZDA SKAFO PREPARATINING KLINIK SAMARADORLIGI VA XAVFSIZLIGI

Digital Object Identifier (DOI) https://doi.org/10.67620/dermajournal.1730025
Eshboyev Egamberdi Husanovich1 , Tog‘ayev Axror Turaqulovich2, Sultanov Akram Abduxolikovich3, Onarov Nodir Norkobilovich4
Received Sep 25, 2026
Revised Oct 10, 2026
Published Oct 15, 2026

Аннотация

Pilakchali psoriazda davolash natijasini teridagi o‘choqlar kamayishi va bemorning hayot sifati orqali baholash zarur. Skafo (Scapho) preparatining faol moddasi sekukinumab bo‘lib, u IL-17A ni selektiv neytrallovchi inson monoklonal antitelosidir. Ushbu ta’sir keratinotsitlardagi yallig‘lanish jarayonlarini susaytiradi. Preparat tizimli davoga nomzod, o‘rta og‘ir va og‘ir pilakchali psoriazli kattalarda qo‘llanadi. Biologik vositani tanlashda klinik javob bilan birga hamroh kasalliklar va xavfsizlikni baholash muhim.

Ключевые слова

—

Как цитировать

APA style
Eshboyev Egamberdi Husanovich (2026). PILAKCHALI PSORIAZDA SKAFO PREPARATINING KLINIK SAMARADORLIGI VA XAVFSIZLIGI. *Dermatovenereology and aesthetic medicine*, 17(3), 47. https://doi.org/10.67620/dermajournal.1730025